Acenocumarol
- Long experience in in-house commercial manufacturing
- No risk of nitrosoamine presence
Status |
Commercial |
Therapeutic cat. |
Cardiology |
CAS No. |
152-72-7 |
EU DMF readiness |

|
Disclaimer
Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).
|